Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
Approach to assessment of liver function in suspected NAFLD:
- Do not rely on routine liver blood tests (LFTs) to diagnose NAFLD or to assess for advanced liver fibrosis, as they may be normal even in progressive disease.
- Take a detailed alcohol history to exclude alcohol-related liver disease.
- Use liver ultrasound to detect hepatic steatosis if NAFLD is suspected, especially in people with type 2 diabetes or metabolic syndrome who do not misuse alcohol.
- Assess risk of advanced liver fibrosis using non-invasive tests such as the enhanced liver fibrosis (ELF) test, NAFLD fibrosis score (NFS), or FIB-4 score rather than routine LFTs.
- Refer patients with high risk of advanced fibrosis (e.g., ELF score ≥10.51) or clinical signs of advanced liver disease to a hepatology specialist for further assessment, which may include transient elastography (FibroScan) or liver biopsy.
- For patients at low risk of advanced fibrosis, manage in primary care with lifestyle advice and reassess fibrosis risk every 3 years using non-invasive tests.
- Monitor and manage associated metabolic risk factors (type 2 diabetes, hypertension, dyslipidaemia) and cardiovascular risk as part of holistic care.
This approach ensures accurate assessment of liver disease severity while avoiding over-reliance on LFTs, which can be misleading in NAFLD.
References: NICE CKS,NICE NG49,NICE NG50